- Home
- VABK vs ALEC Comparison
VABK vs ALEC Comparison
Compare VABK & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VABK | ALEC |
|---|---|---|
| Founded | 1998 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 265.4M | 275.8M |
| IPO Year | 2013 | 2019 |
Fundamental Metrics
Financial Performance| Metric | VABK | ALEC |
|---|---|---|
| Price | $50.44 | $1.84 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $3.90 |
| AVG Volume (30 Days) | 8.0K | ★ 4.0M |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | ★ 2.88% | N/A |
| EPS Growth | ★ 12.70 | N/A |
| EPS | ★ 2.62 | N/A |
| Revenue | N/A | ★ $21,045,000.00 |
| Revenue This Year | N/A | $214.33 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $19.10 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $37.35 | $1.09 |
| 52 Week High | $52.69 | $2.76 |
Technical Indicators
Market Signals| Indicator | VABK | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 57.90 | 44.01 |
| Support Level | $46.42 | $1.43 |
| Resistance Level | N/A | $2.65 |
| Average True Range (ATR) | 1.33 | 0.24 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 54.71 | 10.00 |
Price Performance
Historical ComparisonAbout VABK Virginia National Bankshares Corporation
Virginia National Bankshares Corp is a bank holding company engaged in commercial and retail banking. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts, and other depository services. Its segments include the Bank, VNB Trust and Estate Services, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits, and offering related services to individuals, businesses, and charitable organizations.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.